Other publication

Quantitative drug sensitivity and resistance testing (DSRT) of primary ex vivo AML blasts highlights mTOR and MEK as potential key molecular driver signals of therapeutic significance

Authors: Pemovska T, Kylesskiy E, Kontro M, Szwajda A, Karjalainen R, Majumder MM, Malani D, Bespalov MM, Eldfors S, Elonen E, Knowles J, Murumagi A, Mpindi JP, Edgren H, Venkata NPK, Turunen L, Mustjoki S, Wolf M, Yadav B, Aittokallio T, Heckman CA, Porkka K, Kallioniemi O, Wennerberg K

Publisher: AMER ASSOC CANCER RESEARCH

Publication year: 2012

Journal: Cancer Research

Journal name in source: CANCER RESEARCH

Journal acronym: CANCER RES

Volume: 72

Number of pages: 1

ISSN: 0008-5472

DOI: https://doi.org/10.1158/1538-7445.AM2012-895